FindMyRecallSubscribe
Class I: serious health riskOngoing

Revive Rx LLC dba Revive Rx Pharmacy Tirzepatide 10 mg/0 Recall

Tirzepatide 10 mg/0

Revive Rx LLC dba Revive Rx Pharmacy · Houston, TX

Risk level
Class I
Reported by FDA
Jun 5, 2024
Recall ID
D-0511-2024
Check your lot numberHow we source this data

Summary

Revive Rx LLC dba Revive Rx Pharmacy recalled Tirzepatide 10 mg/0 starting Apr 20, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0511-2024 on Jun 5, 2024. Reason: Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Product description

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Lot numbers, UPCs & expiration codes

Lot #: 748127, Exp 9/24/2024

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0511-2024
Classification
Class I
Status
Ongoing
Recall initiated
Apr 20, 2024
FDA report date
Jun 5, 2024
Quantity
751 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Revive Rx LLC dba Revive Rx Pharmacy

Original FDA data

Every field from FDA enforcement report D-0511-2024, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Ongoing
Country
United States
Event ID
94550
Address
3831 Golf Dr Ste A
Code information
Lot #: 748127, Exp 9/24/2024
Postal code
77018-5218
Report date
Jun 5, 2024
Product type
Drugs
Recall number
D-0511-2024
Classification
Class I
Recalling firm
Revive Rx LLC dba Revive Rx Pharmacy
Product quantity
751 vials
Reason for recall
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
Distribution pattern
USA Nationwide
Recall initiation date
Apr 20, 2024
Initial firm notification
Telephone
Center classification date
May 29, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0511-2024, published Jun 5, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls